FAS-L Antibody

ArtNr	AB-C30517-50
Hersteller	Assay Biotechnology
Menge	50 ul
Quantity options	100 ul 50 ul
Kategorie	Oncology Metabolism Cholesterol & Lipid Metabolism Antibodies By Cell Type Carcinoma Cell Biology Cell Status Apoptosis Immunohistochemistry Western Blot ELISA Immunofluorescence Enzymes Fatty Acid Synthesis Primary Antibodies Immunostaining
Typ	Antibody Polyclonal
Format	Liquid
Applikationen	IF, IHC, ELISA
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host	Rabbit
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand,APTL,CD95 ligand,CD95-L,Fas antigen ligand,Fas ligand,FasL,CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6,membrane form,Tumor necrosis factor ligand superfamily member 6,soluble form (Receptor-binding FasL ectodomain,Soluble Fas ligand,sFasL),ADAM10-processed FasL form (APL),FasL intracellular domain (FasL ICD,SPPL2A-processed FasL form,SPA)]
Lieferbar
Manufacturer - Category	Polyclonal Antibody
Shipping Temperature	4°C
Storage Conditions	Store at -20°C/1 year
Clonality	Polyclonal
Dilution	IHC 1:50-200, ELISA 1:10000-20000. IF 1:50-200
Immunogen	Synthetic peptide from human protein at AA range: 121-170
Purification	The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Product Description	FAS-L Rabbit Polyclonal Antibody
Modifications	Unmodified/Total
Gene Name	FASLG APT1LG1 CD95L FASL TNFSF6
Protein Name	Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane formTumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL)ADAM10-processed FasL form (APL)FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
Formulation	Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

AB-C30517-50-datasheet.pdf

AB-C30517-50-safety-datasheet.pdf